Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: A retrospective pharmacy and medical claims analysis
Open Access
- 1 March 2022
- journal article
- research article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 62 (2) , 526-536.e10
Abstract
No abstract availableKeywords
Funding Information
- Tufts Medical Center
- GlaxoSmithKline (HO-18-19056/ VxHO-000052)
This publication has 23 references indexed in Scilit:
- Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) studyBMC Infectious Diseases, 2014
- Vaccinations Administered During Off-Clinic Hours at a National Community Pharmacy: Implications for Increasing Patient Access and ConvenienceThe Annals of Family Medicine, 2013
- Herpes ZosterNew England Journal of Medicine, 2013
- The Epidemiology and Prevention of Herpes ZosterCurrent Dermatology Reports, 2012
- Disparities in Influenza Vaccine Coverage in the United States, 2008Journal of the American Geriatrics Society, 2010
- The impact of herpes zoster and post-herpetic neuralgia on quality-of-lifeBMC Medicine, 2010
- Compliance With Multiple-Dose Vaccine Schedules Among Older Children, Adolescents, and Adults: Results From a Vaccine Safety Datalink StudyAmerican Journal of Public Health, 2009
- Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis of Disease, and LatencyNeurologic Clinics, 2008
- Recommendations for the Management of Herpes ZosterClinical Infectious Diseases, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005